2.04 Make the most of Denmark’s position of strength Denmark must concentrate on established fields of research in which we already have a global position of strength. Denmark is a small country, and cannot be a leader in all areas. We must therefore concentrate our resources on those areas of strength where we have the potential for continued success. We have that potential in the pharmaceutical and biotechnological field, but we must act to use it.   Health research is approaching a number of future breakthroughs in the under­stand­ing of why diseases arise and of their prevention and treatment. Denmark has the potential to be first with the answers to some of these questions.   But future success in the healthcare field will not happen automatically. It requires that Denmark seizes its opportunity. If the pharmaceutical industry, the biotech industry, decision-makers, hospitals and universities are able to work together with a view to embracing the challenges in health research, a beneficial spiral will be initiated. That will contribute to more knowledge, growth and new jobs in our society.   Accordingly, a strong partnership between enterprises, hospitals, universities and politicians is essential if Denmark wishes to remain an attractive place for research. At the same time, continued success requires that we have proper and competitive framework conditions.   Lif believes: that authorities, universities and enterprises should draw up a strategy for how to improve health research and drug development in Denmark, that the university structure should be developed, on an ongoing basis, with a view to creating the best possible conditions for science and excellence in each of its disciplines, that more PhD graduates should be produced in the natural and health sciences, that new international researchers should be attracted by making it more desirable to work in Denmark, that long-term framework programmes targeted at the generation of new health science breakthroughs should be established.